Congressman Roscoe Bartlett (R-Md.), one of the original sponsors of Holly's Law (H.R. 1079), pointed out that while regular pharmaceutical companies pull their own drugs off the shelves when there are reports of deaths and injuries, the situation with RU486 is different. "Responsible manufacturers pull drugs from the market," Bartlett said in a March 17, 2006, press release. "However, RU486's manufacturer, Danco, is a shell company. Its only product is RU486."

Danco is the U.S. distributor of RU486, created by the Population Council, the U.S. patent holder of the abortion drug. The Population Council is a major player on the international population control scene, developing and promoting various contraceptive and abortion methods.

The FDA's previous pattern has been to collect and publicize data on drug problems and let drug makers pull products with safety problems. But Congressman Bartlett said that in light of the FDA's timidity and Danco's unwillingness to face up to its responsibility in the face of multiple deaths and mounting numbers of injuries, "Congress has to step in and approve Holly's Law to protect women's lives and health from this dangerous drug."

Senator Jim DeMint (R-SC), sponsor of the companion bill in the Senate (S. 511), said in a March 17, 2006, press release that "Congress needs to wake up and force it [the FDA] to pull this drug before more women die. ... The information about these two new deaths clearly indicates a serious risk to women's health."

One of the cosponsors of DeMint's bill, Senator Tom Coburn (R-Ok.), said in the joint release, "When the Clinton administration rushed RU486 to the market in the waning days of its tenure, many medical professionals expressed alarm at the FDA's corner-cutting and lax safety standards for RU486. Tragically, those concerns have been proven to be well founded."

DeMint called RU486 "a deadly drug that is destroying women" and declared that "This drug should never have been approved, and it must be suspended immediately."